|
1
|
Solomon A and Kivipelto M:
Cholesterol-modifying strategies for Alzheimer’s disease. Expert
Rev Neurother. 9:695–709. 2009.PubMed/NCBI
|
|
2
|
Stefani M and Liguri G: Cholesterol in
Alzheimer’s disease: unresolved questions. Curr Alzheimer Res.
6:15–29. 2009.
|
|
3
|
Sparks DL, Scheff SW, Hunsaker JC III, Liu
H, Landers T and Gross DR: Induction of Alzheimer-like beta-amyloid
immuno-reactivity in the brains of rabbits with dietary
cholesterol. Exp Neurol. 126:88–94. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Refolo LM, Malester B, LaFrancois J, et
al: Hypercholesterolemia accelerates the Alzheimer’s amyloid
pathology in a transgenic mouse model. Neurobiol Dis. 7:321–331.
2000.
|
|
5
|
Levin-Allerhand JA, Lominska CE and Smith
JD: Increased amyloid- levels in APPSWE transgenic mice treated
chronically with a physiological high-fat high-cholesterol diet. J
Nutr Health Aging. 6:315–319. 2002.PubMed/NCBI
|
|
6
|
Shie FS, Jin LW, Cook DG, Leverenz JB and
LeBoeuf RC: Diet-induced hypercholesterolemia enhances brain A beta
accumulation in transgenic mice. Neuroreport. 13:455–459. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simons M, Keller P, De Strooper B,
Beyreuther K, Dotti CG and Simons K: Cholesterol depletion inhibits
the generation of beta-amyloid in hippocampal neurons. Proc Natl
Acad Sci USA. 95:6460–6464. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xue QS, Sparks DL and Streit WJ:
Microglial activation in the hippocampus of hypercholesterolemic
rabbits occurs independent of increased amyloid production. J
Neuroinflammation. 4:202007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akiyama H, Barger S, Barnum S, et al:
Inflammation and Alzheimer’s disease. Neurobiol Aging. 21:383–421.
2000.
|
|
10
|
Rogers J: The inflammatory response in
Alzheimer’s disease. J Periodontol. 79(Suppl 8): S1535–S1543.
2008.
|
|
11
|
Takeda S, Sato N, Niisato K, et al:
Validation of Abeta1-40 administration into mouse cerebroventricles
as an animal model for Alzheimer disease. Brain Res. 1280:137–147.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casserly I and Topol E: Convergence of
atherosclerosis and Alzheimer’s disease: inflammation, cholesterol,
and misfolded proteins. Lancet. 363:1139–1146. 2004.
|
|
13
|
Sjogren M, Mielke M, Gustafson D, Zandi P
and Skoog I: Cholesterol and Alzheimer’s disease - is there a
relation? Mech Ageing Dev. 127:138–147. 2006.
|
|
14
|
Canevari L and Clark JB: Alzheimer’s
disease and cholesterol: the fat connection. Neurochem Res.
32:739–750. 2007.
|
|
15
|
van Vliet P, van de Water W, de Craen AJ
and Westendorp RG: The influence of age on the association between
cholesterol and cognitive function. Exp Gerontol. 44:112–122.
2009.
|
|
16
|
Cedazo-Minguez A, Ismail MA and Mateos L:
Plasma cholesterol and risk for late-onset Alzheimer’s disease.
Expert Rev Neurother. 11:495–498. 2011.
|
|
17
|
Ghribi O: Potential mechanisms linking
cholesterol to Alzheimer’s disease-like pathology in rabbit brain,
hippocampal organotypic slices, and skeletal muscle. J Alzheimers
Dis. 15:673–684. 2008.
|
|
18
|
Simons M, Keller P, Dichgans J and Schulz
JB: Cholesterol and Alzheimer’s disease: is there a link?
Neurology. 57:1089–1093. 2001.
|
|
19
|
Sharma S, Prasanthi RPJ, Schommer E, Feist
G and Ghribi O: Hypercholesterolemia-induced Abeta accumulation in
rabbit brain is associated with alteration in IGF-1 signaling.
Neurobiol Dis. 32:426–432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghribi O, Larsen B, Schrag M and Herman
MM: High cholesterol content in neurons increases BACE,
beta-amyloid, and phosphorylated tau levels in rabbit hippocampus.
Exp Neurol. 200:460–467. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fitz NF, Cronican A, Pham T, et al: Liver
X receptor agonist treatment ameliorates amyloid pathology and
memory deficits caused by high-fat diet in APP23 mice. J Neurosci.
30:6862–6872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ullrich C, Pirchl M and Humpel C:
Hypercholesterolemia in rats impairs the cholinergic system and
leads to memory deficits. Mol Cell Neurosci. 45:408–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schreurs BG: The effects of cholesterol on
learning and memory. Neurosci Biobehav Rev. 34:1366–1379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao D, Fukuchi K, Wan H, Kim H and Li L:
Lack of LDL receptor aggravates learning deficits and amyloid
deposits in Alzheimer transgenic mice. Neurobiol Aging.
27:1632–1643. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Evola M, Hall A, Wall T, Young A and
Grammas P: Oxidative stress impairs learning and memory in apoE
knockout mice. Pharmacol Biochem Behav. 96:181–186. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thirumangalakudi L, Prakasam A, Zhang R,
et al: High cholesterol-induced neuroinflammation and amyloid
precursor protein processing correlate with loss of working memory
in mice. J Neurochem. 106:475–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heneka MT and O’Banion MK: Inflammatory
processes in Alzheimer’s disease. J Neuroimmunol. 184:69–91.
2007.
|
|
28
|
Perry VH, Newman TA and Cunningham C: The
impact of systemic infection on the progression of
neurodegenerative disease. Nat Rev Neurosci. 4:103–112. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yankner BA, Duffy LK and Kirschner DA:
Neurotrophic and neurotoxic effects of amyloid beta protein:
reversal by tachykinin neuropeptides. Science. 250:279–282. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamada K and Nabeshima T: Animal models of
Alzheimer’s disease and evaluation of anti-dementia drugs.
Pharmacol Ther. 88:93–113. 2000.
|
|
31
|
Kim DH, Kim S, Jeon SJ, et al: The effects
of acute and repeated oroxylin A treatments on Abeta(25–35)-induced
memory impairment in mice. Neuropharmacology. 55:639–647.
2008.PubMed/NCBI
|
